DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Jabbour E, Kantarjian H, Ravandi F. et al.
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Lancet Oncol 2015;
16 (15) 1547-1555
We do not assume any responsibility for the contents of the web pages of other providers.